ProAxsis
Matthew McCaffrey is a skilled Research and Development Scientist at ProAxsis since July 2022, with a prior role at the same company as a Laboratory Assistant from August 2020 to September 2021, where responsibilities included handling human tissue samples, conducting production and quality control, and performing various ELISAs. Currently involved in Building Operations at Queen's University Belfast since September 2021, Matthew has a solid educational background with a Bachelor of Science in Biochemistry with Professional Studies from Queen's University Belfast, completed in September 2022. Prior to the scientific roles, Matthew gained customer service experience as a Sales Assistant at Dunnes Stores from November 2017 to September 2021.
This person is not in any teams
ProAxsis
ProAxsis Ltd. specialises in the development of laboratory-based immunoassays and rapid point-of-care tests for the capture, detection and measurement of active protease biomarkers of disease.Its rapid and easy-to-use tests incorporate patented “ProteaseTags®”; smart molecules which trap an active protease within a complex biological sample andenable a visual readout of its presence. A number of active protease species have been extensively validated as biomarkers of disease activity in areas such as cancer and infection, in addition to respiratory diseases such as bronchiectasis, cystic fibrosis and COPD. Its first immunoassay, for the specific measurement of active neutrophil elastase as a biomarker of lung infection and inflammation, was registered with a European CE Mark in 2016.